Form 4 for CGON CG Oncology, Inc.
Accepted 2026-06-05 16:30:07 ET · period of report 2026-06-04 · accession 0001193125-26-259705 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-05 16:30 | 2026-06-04 | CGON | POST LEONARD E | Dir | M - OptEx | $0.6 | +1,000 | 1,000 | New | +$600 |
| DT | 2026-06-05 16:30 | 2026-06-04 | CGON | POST LEONARD E | Dir | S - Sale+OE | $54.50 | -1,000 | 0 | -100% | -$54.5K |
| DT | 2026-06-05 16:30 | 2026-06-04 | CGON | POST LEONARD E | Dir | M - OptEx | $0.00 | -1,000 | 116.1K | -0.9% | $0 |
| DT | 2026-06-05 16:30 | 2026-06-04 | CGON | POST LEONARD E | Dir | A - Grant | $0.00 | +9,354 | 9,354 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-04 | M | A | 1,000 | $0.6 | 1,000 | D | — | — | (F1) The option exercise and sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026 |
| 2 | Common | Common Stock | 2026-06-04 | S | D | 1,000 | $54.50 | 0 | D | — | — | (F1) The option exercise and sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026 |
| 3 | Derivative | Director Stock Option (right to buy) | 2026-06-04 | M | D | 1,000 | $0.00 | 116,077 | D | $0.6 · — to 2028-07-08 | 1,000 Common Stock | (F1) The option exercise and sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026 (F2) Fully vested. |
| 4 | Derivative | Director Stock Option (right to buy) | 2026-06-04 | A | A | 9,354 | $0.00 | 9,354 | D | $56.09 · — to 2036-06-03 | 9,354 Common Stock | (F3) 1/12th of the total number of shares of common stock subject to the option vest monthly following June 4, 2026, the date of grant (or, in the event the next annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of this stock option will vest on the date of such annual meeting of the Issuer's stockholders), subject to the Reporting Person's continuous service to the Issuer through each vesting date. |